Mirum Pharmaceuticals Stock Analysis

Mirum Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.85. Mirum Pharmaceuticals had not issued any dividends in recent years. Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California. Mirum Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 171 people. To find out more about Mirum Pharmaceuticals contact Christopher Peetz at 650 667 4085 or learn more at https://www.mirumpharma.com.

Mirum Pharmaceuticals Investment Alerts

Mirum Pharmaceuticals Upcoming and Recent Events

Mirum Pharmaceuticals Thematic Classifications

Mirum Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.16 B.

Mirum Profitablity

The company has Profit Margin (PM) of (0.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.24.

Technical Drivers

As of the 4th of May, Mirum Pharmaceuticals secures the Standard Deviation of 2.49, mean deviation of 1.89, and Risk Adjusted Performance of (0.09). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mirum Pharmaceuticals, as well as the relationship between them. Please verify Mirum Pharmaceuticals market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Mirum Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 43.69 per share. Given that Mirum Pharmaceuticals has information ratio of (0.01), we recommend you to check Mirum Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.

Mirum Pharmaceuticals Price Movement Analysis

Mirum Pharmaceuticals Insider Trading Activities

Mirum Pharmaceuticals Outstanding Bonds

Mirum Pharmaceuticals Predictive Daily Indicators

Mirum Pharmaceuticals Forecast Models

Mirum Pharmaceuticals' time-series forecasting models are one of many Mirum Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mirum Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mirum Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mirum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mirum Pharmaceuticals. By using and applying Mirum Stock analysis, traders can create a robust methodology for identifying Mirum entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.